当前位置:首页 - 行情中心 - 康弘药业(002773) - 财务分析 - 现金流量表

康弘药业

(002773)

  

流通市值:134.28亿  总市值:180.12亿
流通股本:6.87亿   总股本:9.21亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,258,102,179.781,172,035,090.594,967,274,679.873,867,965,865.99
  收到的税费返还451,348.16---
  收到其他与经营活动有关的现金44,994,769.6820,849,109.98128,802,523.9118,373,151.67
  经营活动现金流入小计2,303,548,297.621,192,884,200.575,096,077,203.773,986,339,017.66
  购买商品、接受劳务支付的现金182,238,401.6583,183,428.62310,805,097.09209,154,428.35
  支付给职工以及为职工支付的现金643,498,847.78370,214,374.441,301,289,008.41,001,232,591.36
  支付的各项税费336,339,829.22138,049,510.14434,846,130.68329,038,713.95
  支付其他与经营活动有关的现金601,699,478.6257,126,175.991,545,488,514.881,038,637,595.98
  经营活动现金流出小计1,763,776,557.25848,573,489.193,592,428,751.052,578,063,329.64
  经营活动产生的现金流量净额539,771,740.37344,310,711.381,503,648,452.721,408,275,688.02
二、投资活动产生的现金流量:
  收回投资收到的现金1,240,000,000-5,955,000,0003,240,000,000
  取得投资收益收到的现金3,175,854.44-36,883,259.6511,533,310.23
  处置固定资产、无形资产和其他长期资产收回的现金净额35,872.6127,567.61214,808.0977,489.76
  收到的其他与投资活动有关的现金150,000-1,270,000860,000
  投资活动现金流入小计1,243,361,727.0527,567.615,993,368,067.743,252,470,799.99
  购建固定资产、无形资产和其他长期资产支付的现金144,521,989.569,554,905.95262,480,608.58179,453,898.11
  投资支付的现金4,159,000,000440,000,0005,955,000,0005,805,000,000
  支付其他与投资活动有关的现金1,170,458.17200,0001,254,000650,000
  投资活动现金流出小计4,304,692,447.67509,754,905.956,218,734,608.585,985,103,898.11
  投资活动产生的现金流量净额-3,061,330,720.62-509,727,338.34-225,366,540.84-2,732,633,098.12
三、筹资活动产生的现金流量:
  吸收投资收到的现金74,736-35,067,48535,047,485
  其中:子公司吸收少数股东投资收到的现金--1,830,0001,810,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计74,736-35,067,48535,047,485
  分配股利、利润或偿付利息支付的现金499,519,954.5-552,673,862.4552,673,862.4
  支付其他与筹资活动有关的现金1,418,421.881,267,868.411,916,316.571,485,890.36
  筹资活动现金流出小计500,938,376.381,267,868.41554,590,178.97554,159,752.76
  筹资活动产生的现金流量净额-500,863,640.38-1,267,868.41-519,522,693.97-519,112,267.76
四、汇率变动对现金及现金等价物的影响-247,626.47-157,509.87-482,965.57-551,595.52
五、现金及现金等价物净增加额-3,022,670,247.1-166,842,005.24758,276,252.34-1,844,021,273.38
  加:期初现金及现金等价物余额6,383,703,498.96,383,703,498.95,625,427,246.565,625,427,246.56
  期末现金及现金等价物余额3,361,033,251.86,216,861,493.666,383,703,498.93,781,405,973.18
补充资料:
  净利润554,945,878.85-1,145,503,613.71-
  资产减值准备4,461,778.68-7,985,713.08-
  固定资产和投资性房地产折旧104,601,471.74-199,296,374.84-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧104,601,471.74-199,296,374.84-
  无形资产摊销19,933,546.36-37,074,895.78-
  长期待摊费用摊销286,025.53-5,789,209.17-
  处置固定资产、无形资产和其他长期资产的损失61,057.22--9,782.42-
  固定资产报废损失836,898.7-598,226.96-
  公允价值变动损失-1,569,600--550,600-
  财务费用279,447.91-402,269.43-
  投资损失-8,361,729.37--36,236,443.63-
  递延所得税26,919,080.8-127,152,034.56-
  其中:递延所得税资产减少25,837,465.95-130,605,127.48-
    递延所得税负债增加1,081,614.85--3,453,092.92-
  存货的减少1,837,626--22,160,586.1-
  经营性应收项目的减少-167,202,874.93--3,007,100.78-
  经营性应付项目的增加3,971,477.02-37,988,875.41-
  其他-2,088,585.13-2,052,907.36-
  现金的期末余额3,361,033,251.8-6,383,703,498.9-
  减:现金的期初余额6,383,703,498.9-5,625,427,246.56-
  现金及现金等价物的净增加额-3,022,670,247.1-758,276,252.34-
公告日期2026-08-262026-04-232026-04-232025-10-29
审计意见(境内)标准无保留意见
TOP↑